August 2017

Spectranetics Completes $2.2 Billion Sale to Royal Phillips

North America - United States | Europe | Europe - Netherlands | United States - Colorado

Spectranetics, a U.S.-based vascular intervention device maker, completed a $2.2 billion sale to Royal Philips. Spectranetics' portfolio of devices will aid Philips' strategic expansion into therapy devices. Our firm represented Spectranetics in the sale, applying our deep experience in the medical device industry and specific knowledge of Spectranetics’ strategic goals to allow the company to capitalize on previous acquisitions we had led for it and create a significant value for its shareholders.

Related Legal Services

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.